Author:
Dong Xiangning,Xue Song,Chen Chen,Jiang Zonghui,Wu Xiangdu,Wang Weifei
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,General Medicine,Bioengineering,Biotechnology
Reference32 articles.
1. Rawla, P., & Barsouk, A. (2019). Epidemiology of gastric cancer: Global trends, risk factors and prevention. Gastroenterology Review/Przegląd Gastroenterologiczny, 14(1), 26–38.
2. Zalata, K. R., Elshal, M. F., Foda, A. A., & Shoma, A. (2015). Genetic dissimilarity between primary colorectal carcinomas and their lymph node metastases: Ploidy, p53, bcl-2, and c-myc expression--A pilot study. Tumour Biology, 36(8), 6579–6584.
3. Yue, P. J., Sun, Y. Y., Li, Y. H., Xu, Z. M., & Fu, W. N. (2020). MYCT1 inhibits the EMT and migration of laryngeal cancer cells via the SP1/miR-629-3p/ESRP2 pathway. Cellular Signalling, 74, 109709.
4. Pu, J., Wang, J., Xu, Z., Lu, Y., Wu, X., Wu, Y., Shao, Z., Tang, Q., & Wei, H. (2019). miR-632 functions as oncogene in hepatocellular carcinoma via targeting MYCT1. Human Gene Therapy. Clinical Development, 30(2), 67–73.
5. Fu, S., Fu, Y., Chen, F., Hu, Y., Quan, B., & Zhang, J. (2018). Overexpression of MYCT1 inhibits proliferation and induces apoptosis in human acute myeloid leukemia HL-60 and KG-1a cells in vitro and in vivo. Frontiers in Pharmacology, 9, 1045.